Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OPPS Proposed Rule In Brief

This article was originally published in The Gray Sheet

Executive Summary

Outlier threshold tightened: CMS takes steps to "redirect outlier payments from lower-cost and relatively simple procedures to more complex, expensive procedures," according to the 2005 hospital outpatient prospective payment system proposed rule. The agency would require the cost of the service to be 1.5 times the APC payment rate and surpass the sum of the APC rate plus a $625 fixed-dollar threshold. CMS' action arises from a Medicare Payment Advisory Commission recommendation that the outlier policy be eliminated due to misuse of payments intended for high-cost cases (1"The Gray Sheet" Jan. 19, 2004, p. 14). AdvaMed and the American Hospital Association support the proposal...

You may also be interested in...



IMRT Outpatient Payment Drop Should Be Halted – APC Advisory Panel

Intensity modulated radiation therapy should be kept in a new technology APC for one year to allow more data to be gathered in order to set a more accurate payment than the 2004 amount, according to the Ambulatory Payment Classification Advisory Panel

MedPAC Votes To Oust Medicare Hospital Outpatient Outlier System

Congress should eliminate Medicare's outlier policy under the hospital OPPS and return the funds to the payment baseline, the MedPAC recommended Jan. 15 in Washington, D.C

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020733

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel